DE69125066D1 - cDNS-Sequenz und Detektion des Hepatitis C-Virus - Google Patents

cDNS-Sequenz und Detektion des Hepatitis C-Virus

Info

Publication number
DE69125066D1
DE69125066D1 DE69125066T DE69125066T DE69125066D1 DE 69125066 D1 DE69125066 D1 DE 69125066D1 DE 69125066 T DE69125066 T DE 69125066T DE 69125066 T DE69125066 T DE 69125066T DE 69125066 D1 DE69125066 D1 DE 69125066D1
Authority
DE
Germany
Prior art keywords
hepatitis
virus
detection
cdna sequence
pcr technique
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69125066T
Other languages
English (en)
Other versions
DE69125066T2 (de
Inventor
Takenobu Kamada
Norio Hayashi
Eiji Mita
Keiji Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP41217790A external-priority patent/JPH04218376A/ja
Priority claimed from JP2936491A external-priority patent/JPH04218377A/ja
Priority claimed from JP4285591A external-priority patent/JPH04262784A/ja
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE69125066D1 publication Critical patent/DE69125066D1/de
Publication of DE69125066T2 publication Critical patent/DE69125066T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69125066T 1990-07-11 1991-07-09 cDNS-Sequenz und Detektion des Hepatitis C-Virus Expired - Fee Related DE69125066T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18351290 1990-07-11
JP41217790A JPH04218376A (ja) 1990-12-18 1990-12-18 Ｃ型肝炎ウィルスのｃＤＮＡ配列
JP2936491A JPH04218377A (ja) 1990-07-11 1991-01-30 Ｃ型肝炎ウイルスのｃＤＮＡ配列および検出方法
JP4285591A JPH04262784A (ja) 1991-02-14 1991-02-14 Ｃ型肝炎ウイルスのｃＤＮＡ配列および検出方法

Publications (2)

Publication Number Publication Date
DE69125066D1 true DE69125066D1 (de) 1997-04-17
DE69125066T2 DE69125066T2 (de) 1997-09-25

Family

ID=27459049

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125066T Expired - Fee Related DE69125066T2 (de) 1990-07-11 1991-07-09 cDNS-Sequenz und Detektion des Hepatitis C-Virus

Country Status (6)

Country Link
EP (1) EP0469348B1 (de)
AT (1) ATE150086T1 (de)
DE (1) DE69125066T2 (de)
DK (1) DK0469348T3 (de)
ES (1) ES2100185T3 (de)
GR (1) GR3023251T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL169035B1 (pl) * 1990-08-10 1996-05-31 Chiron Corp Sposób wykrywania sekwencji HCV PL
ATE241704T1 (de) * 1991-08-27 2003-06-15 Hoffmann La Roche Primers und sondern zum nachweis von hepatitis c
ES2044784B1 (es) * 1992-06-12 1994-09-01 Inia Procedimiento para la deteccion e identificacion de patogenos virales y subvirales.
SG46456A1 (en) 1992-11-27 1998-02-20 Innogenetics Nv Process for typing of hcv isolates
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE318216T1 (de) * 1987-11-18 1990-06-13 Chiron Corp., Emeryville, Calif., Us Nanbv-diagnostika und vakzine.
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
MC2188A1 (fr) * 1989-05-18 1992-09-16 Chiron Corp Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates

Also Published As

Publication number Publication date
GR3023251T3 (en) 1997-07-30
EP0469348A3 (de) 1992-02-12
EP0469348A2 (de) 1992-02-05
DE69125066T2 (de) 1997-09-25
EP0469348B1 (de) 1997-03-12
DK0469348T3 (da) 1997-04-01
ES2100185T3 (es) 1997-06-16
ATE150086T1 (de) 1997-03-15

Similar Documents

Publication Publication Date Title
ATE231557T1 (de) Detektion des hepatis-c virus.
ATE553201T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
DE68903165T2 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
ATE507312T1 (de) Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
DK0702085T4 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DK0386734T3 (da) Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
DE68927025T2 (de) HIV-2-Virusvarianten
ATE17320T1 (de) Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben.
ATE171710T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
DE69333914D1 (de) Verfahren und zusammensetzungen zur kontrolle der übersetzung der hcv-proteine
DE69125066D1 (de) cDNS-Sequenz und Detektion des Hepatitis C-Virus
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
DK498387D0 (da) Virus-dna-sekvens
DK76688A (da) Vaccine indeholdende f-proteinet fra aids-virus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee